Biotech Late Stage Investors & VC Firms
360 firms in this list, with a median first check of $1M. 82 of them lead rounds. Generated from verified public data and updated continuously.
Venbridge
TorontoSeed–Late Stage
1 person
Shinsei Capital Partners
TokyoPre-Seed–Late Stage
Ambix Venture Management, Llc
Mountain ViewPre-Seed–Late Stage
2 people
SymBiosis
BentonvilleSeed–Late Stage
4 people
Boxer Capital, LLC
San DiegoSeed–Late Stage
1 person
E15
Hong KongPre-Seed–Late Stage
1 person
East West Capital Limited
SydneySeed–Late Stage
1 person
Panda Capital
Seed–Late Stage
1 person
Arix Bioscience
LondonSeed–Late Stage
4 people
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
Ikarian Capital
DallasSeries A–Late Stage
ABICO Asia Capital Corporation
TaipeiGrowth–Late Stage
1 person
Avon River Ventures
Growth–Late Stage
1 person
Bija Ventures
AspenGrowth–Late Stage
1 person
Bioscience Equity Partners
DubaiLate Stage
1 person
JMCR Partners
Hong KongSeed–Late Stage
Seoul Investment Partners
SeoulSeed–Late Stage
The Wells Investment
SeoulSeed–Late Stage
Action Potential Venture Capital Ltd.
Scotts ValleySeed–Late Stage
3 people
Estari Group
LondonLate Stage
Onex Corporation
TorontoGrowth–Late Stage
Shiyu Capital
HainanSeed–Late Stage
CDF-Capital
ShenzhenSeed–Late Stage
Kearny Venture Associates Iii, Llc
Late Stage
Related lists
Biotech Investors & VC Firms (2585)Biotech Seed Investors & VC Firms (2105)Late Stage Investors & VC Firms (1710)Biotech Series A Investors & VC Firms (1693)Biotech Investors & VC Firms in North America (1688)Biotech Investors & VC Firms in United States (1535)Biotech Investors & VC Firms in Europe (990)Biotech Pre-Seed Investors & VC Firms (987)Late Stage Investors & VC Firms in North America (915)Biotech Investors & VC Firms in Global (887)
Data sourced from public filings and firms' own websites — see our methodology.


















